Characteristics of non-randomised studies of drug treatments Post date 30 October 2024 ← Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis → Risk of dementia associated with anticholinergic drugs for overactive bladder in adults aged ≥55 years